ARTICLE | Clinical News
FDA approves Icon Bioscience's Dexycu
February 23, 2018 8:16 PM UTC
Icon Bioscience Inc. (Sunnyvale, Calif.) said FDA approved an NDA for Dexycu dexamethasone intraocular suspension to treat inflammation associated with cataract surgery...
BCIQ Company Profiles